YIP'S CHEMICAL (00408) disclosed that on 27 March 2026 its board granted 2.05 million share options to employees and one director under the 2022 Share Option Scheme adopted on 6 June 2022. Every option entitles the holder to subscribe for one ordinary share.
The exercise price is fixed at HK$2.24 per share, equal to the 27 March 2026 closing price and above the five-day average of HK$2.15. The grant represents approximately 0.36% of the company’s issued share capital.
All options carry a two-year cliff vesting schedule, becoming exercisable on 27 March 2028. Vested options may be exercised from that date until 5 June 2032, within the scheme’s remaining term. Standard lapse provisions apply for cessation of employment, misconduct, insolvency or other disqualifying events; no additional clawback terms or performance hurdles have been set.
Allocation highlights: • Executive Director and Chief Executive Officer Ip Kwan received 0.50 million options. • The balance of 1.55 million options went to other employees and senior managers.
The independent non-executive directors approved the award to Mr Ip, and the overall grant complies with Listing Rule 17.04(1). No grantee exceeds individual limits under the Listing Rules.
Following this issuance, 54.80 million shares remain available for future grants under the scheme mandate of 56.85 million shares (10% of shares outstanding at adoption). No financial assistance will be provided for option exercises.
The board stated that the grant is intended to recognise past contributions, align employee interests with shareholders and strengthen long-term retention and growth incentives across the group.
Comments